RETATRUTIDE 40MG

RETATRUTIDE 40MG is a premium lyophilized peptide intended for laboratory and scientific research use only. Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors, making it a significant area of study in metabolic and obesity research. It is being investigated for its potential effects on body weight regulation, glucose metabolism, appetite control, and energy expenditure.

Product Features

• Strength: 40 mg per vial

• Form: Lyophilized (freeze-dried) powder

• High purity and quality

• Manufactured under strict quality control standards

• Securely sealed sterile vial

• 
  

Research Applications

Retatrutide is currently being studied in preclinical and clinical research involving:

• Metabolic regulation

• Obesity and weight management

• Glucose homeostasis

• Energy expenditure

• Appetite signaling

• 
  

Storage

Store refrigerated at 2–8°C, protected from light and moisture. For research handling only.

Important Notice

This product is intended strictly for laboratory research purposes only. It is not approved for human or veterinary use, and it is not intended to diagnose, treat, cure, or prevent any disease. Retatrutide remains an investigational compound and has not received general regulatory approval for clinical use.